HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Udo Jeschke Selected Research

Paraffin

1/2013Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression.
5/2012Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.
12/2011Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.
5/2010Expression of the carbohydrate tumor marker Sialyl Lewis a (Ca19-9) in squamous cell carcinoma of the larynx.
5/2010Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
5/2010Glycodelin expression in correlation to grading, nodal involvement and steroid receptor expression in human breast cancer patients.
4/2009Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.
9/2008Distribution and maturity of dendritic cells in diseases of insufficient placentation.
9/2008The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO.
7/2007Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Udo Jeschke Research Topics

Disease

31Neoplasms (Cancer)
05/2013 - 01/2005
22Breast Neoplasms (Breast Cancer)
05/2013 - 01/2005
18Carcinoma (Carcinomatosis)
01/2013 - 01/2005
12Ovarian Neoplasms (Ovarian Cancer)
02/2013 - 09/2008
9Neoplasm Metastasis (Metastasis)
12/2011 - 01/2005
9Endometrial Neoplasms (Endometrial Cancer)
09/2010 - 07/2007
7Pre-Eclampsia (Preeclampsia)
03/2012 - 12/2005
6Spontaneous Abortion (Miscarriage)
01/2013 - 05/2008
6Adenocarcinoma
12/2011 - 01/2003
5Inflammation
04/2013 - 03/2009
5Endometriosis (Adenomyosis)
03/2013 - 01/2009
5Trophoblastic Neoplasms (Trophoblastic Tumor)
01/2013 - 06/2004
5Fetal Growth Retardation (Intrauterine Growth Retardation)
09/2008 - 12/2005
5Carcinoma in Situ
07/2007 - 03/2005
5Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007 - 01/2005
4Ductal Carcinoma
05/2009 - 01/2005
3Infection
04/2013 - 01/2009
3Choriocarcinoma
06/2012 - 06/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2011 - 05/2005
3Endometrioid Carcinoma
09/2010 - 05/2005
3Hydatidiform Mole (Molar Pregnancy)
12/2008 - 07/2007
3Hemolysis
09/2008 - 11/2006
3HELLP Syndrome
09/2008 - 02/2007
3Hyperplasia
01/2006 - 01/2003
3Polyps
06/2005 - 01/2003
2Leiomyosarcoma
01/2013 - 02/2011
2Habitual Abortion (Recurrent Miscarriage)
01/2013 - 12/2010
2Leiomyoma (Uterine Fibroids)
01/2013 - 02/2011
2Myoma
01/2013 - 02/2011
2Ovarian Diseases (Ovarian Disease)
01/2012 - 01/2012
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
08/2010 - 01/2009
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
07/2007 - 05/2005
2Breast Ductal Carcinoma
07/2007 - 05/2005
1Premature Birth (Birth, Premature)
04/2013
1Hyperthyroidism
01/2013
1Hypothyroidism
01/2013

Drug/Important Bio-Agent (IBA)

22ParaffinIBA
01/2013 - 01/2003
15AntigensIBA
05/2013 - 05/2005
12HormonesIBA
03/2013 - 06/2004
11Inhibins (Inhibin)IBA
09/2010 - 01/2005
9Estrogens (Estrogen)FDA Link
03/2013 - 07/2007
9Mucin-1 (CA 15-3 Antigen)IBA
01/2013 - 07/2007
9Monoclonal AntibodiesIBA
05/2012 - 01/2005
9Activins (Activin)IBA
09/2010 - 01/2005
8Galectin 1 (LGALS1)IBA
05/2012 - 06/2004
8Estrogen Receptor alphaIBA
03/2010 - 12/2005
7AntibodiesIBA
02/2013 - 05/2005
7Messenger RNA (mRNA)IBA
01/2013 - 03/2005
71-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
05/2012 - 06/2004
7Steroid Receptors (Steroid Receptor)IBA
05/2010 - 05/2005
6Estrogen Receptor betaIBA
01/2009 - 12/2005
5Glycoproteins (Glycoprotein)IBA
01/2013 - 01/2007
5Cadherins (E-Cadherin)IBA
01/2013 - 05/2005
5tranilast (N 5')IBA
04/2010 - 01/2003
4Estradiol (Estrace)FDA LinkGeneric
01/2013 - 07/2007
45- acetylneuraminyl- 2- 3- galactosyl- 1- 3- (fucopyranosyl- 1- 4)- N- acetylglucosamineIBA
05/2012 - 05/2005
4Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2012 - 07/2007
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2010 - 12/2008
4PPAR gammaIBA
04/2010 - 09/2007
3Thomsen-Friedenreich antigenIBA
05/2013 - 01/2007
3Biological Markers (Surrogate Marker)IBA
04/2013 - 01/2012
3GTP-Binding Proteins (G-Protein)IBA
03/2013 - 11/2012
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2013 - 05/2010
3Galectin 3 (LGALS3)IBA
01/2013 - 02/2011
3Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 07/2007
3ProgesteroneFDA LinkGeneric
01/2012 - 07/2007
3inhibin beta A subunitIBA
05/2009 - 01/2005
3progesterone receptor AIBA
04/2009 - 07/2007
35- acetylneuraminyl- (2- 3)- galactosyl- (1- 4)- (fucopyranosyl- (1- 3))- N- acetylglucosamine (sialyl Lewis x)IBA
02/2009 - 05/2005
3EnzymesIBA
09/2008 - 11/2006
2Formaldehyde (Formol)FDA Link
01/2013 - 07/2007
2GonadotropinsIBA
01/2013 - 01/2012
2CytokinesIBA
01/2012 - 09/2008
2LH Receptors (LH Receptor)IBA
01/2012 - 05/2011
2tyrosine receptor (receptor, tyrosine)IBA
12/2011 - 06/2011
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2011 - 06/2011
2Phosphotransferases (Kinase)IBA
12/2011 - 06/2011
2Immunoglobulin M (IgM)IBA
05/2010 - 05/2005
2inhibin-alpha subunitIBA
05/2009 - 07/2007
2Estrogen ReceptorsIBA
07/2007 - 07/2007
2Cathepsin DIBA
07/2007 - 05/2005
2Hydrocortisone (Cortisol)FDA LinkGeneric
07/2007 - 07/2007
2Biological Tumor Markers (Tumor Markers)IBA
07/2007 - 07/2007
2Nitric Oxide Synthase (NO Synthase)IBA
11/2006 - 12/2005
2TamoxifenFDA LinkGeneric
06/2005 - 01/2003
1Carbon MonoxideIBA
05/2013
1Interleukin-10 (Interleukin 10)IBA
04/2013
1Interleukin-4 (Interleukin 4)IBA
04/2013
1InterleukinsIBA
04/2013
1Interleukin-8 (Interleukin 8)IBA
04/2013
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
02/2013
1UrocortinsIBA
01/2013
1liver X receptorIBA
01/2013
1AutoantibodiesIBA
01/2013
1Corticotropin-Releasing HormoneIBA
01/2013
1IodineIBA
01/2013
1NeuropeptidesIBA
01/2013
1FSH Receptors (FSH Receptor)IBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2013

Therapy/Procedure

1Cesarean Section (Caesarean Section)
04/2013